Skip to main content
Macrogen, Inc. logo

Macrogen, Inc. — Investor Relations & Filings

Ticker · 038290 ISIN · KR7038290003 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2018-12-24 Transaction in Own Shar…
Country KR South Korea
Listing KO 038290

About Macrogen, Inc.

https://www.macrogen.com/en/main

Macrogen, Inc. is a biotechnology company specializing in precision medicine and genomic analysis. It provides a comprehensive suite of services, including Next-Generation Sequencing (NGS), Sanger sequencing, and spatial transcriptome analysis, to a global client base. The company's core activities are focused on three key areas: Research and Data Analysis, offering fast and accurate genomic services to the scientific community; Clinical Diagnostics, advancing disease prediction through the integration of genomic and medical big data; and Personal Healthcare, providing genetic tests for wellness, nutrition, and disease risk assessment. By combining its extensive genomic expertise with big data and AI, Macrogen aims to deliver hyper-personalized healthcare solutions and innovate in the field of future medicine.

Recent filings

Filing Released Lang Actions
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding the termination of a treasury stock trust agreement (자기주식취득 신탁계약 해지 결정). This type of filing relates to the company's management of its own shares, specifically the termination of a trust contract and the subsequent return of shares to the company's account. Under the provided categories, this falls under 'Transaction in Own Shares' (POS), as it details the status and movement of treasury shares resulting from the termination of a trust agreement.
2018-12-24 Korean
주요사항보고서(자기주식취득신탁계약해지결정)
Transaction in Own Shares Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the termination of a treasury stock trust agreement (자기주식취득 신탁계약 해지 결정). This type of filing relates to the company's capital structure and treasury share management. Since it specifically details the termination of a trust contract involving the company's own shares, it falls under the category of 'Transaction in Own Shares' (POS), which covers share buybacks and related trust contract activities.
2018-12-24 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 95% confidence The document is a 'Trust Agreement Termination Result Report' (신탁계약해지결과보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a trust contract used for share buybacks and the subsequent status of the company's treasury shares. Since this document reports on the company's own share transactions and the status of its treasury shares following the termination of a trust, it falls under the category of 'Transaction in Own Shares' (POS).
2018-12-24 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 95% confidence The document is a '신탁계약해지결과보고서' (Report on the Termination of a Trust Agreement) filed by Macrogen with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a trust contract related to treasury shares (자기주식 특정금전신탁). In the context of financial filings, reports regarding the acquisition, disposal, or termination of trust contracts involving a company's own shares are classified as 'Transaction in Own Shares' (POS).
2018-12-24 Korean
신탁계약해지결과보고서
Transaction in Own Shares Classification · 95% confidence The document is a 'Trust Contract Termination Report' (신탁계약해지결과보고서) filed by Macrogen with the Financial Supervisory Service (FSS) in South Korea. It details the termination of a trust contract used for share buybacks and the subsequent status of the company's treasury shares. Since this document reports on the conclusion of a share repurchase program (a transaction involving the company's own shares), it falls under the 'Transaction in Own Shares' category.
2018-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register (stock name transfer suspension) for the purpose of determining shareholders for the 23rd Annual General Meeting. It does not contain full financial statements or meeting materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2018-12-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.